CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing public-private sector funding for bioinformatics services
4.1.2. Growing applications of bioinformatics in various industries
4.1.3. Growth in the number of collaborations between companies and research institutes.
4.2. Market Restraints & Challenges
4.2.1. Lack of well-defined standards and common data formats for integration of data.
4.2.2. Lack of user-friendly tools
4.3. Market Opportunities
4.3.1. Growing applications of bioinformatics in various industries
4.3.2. Emerging markets
CHAPTER 5. GLOBAL BIOINFORMATICS SERVICES MARKET – BY TYPE
5.1. Introduction
5.2. Sequencing services
5.2.1 whole genome sequencing and de novo Assembly
5.2.2. Exome analysis
5.2.3. Transcriptome analysis
5.3. Data analysis
5.3.1. Data Mining
5.3.2. Genomic Analysis
5.3.3. Proteomic Analysis
5.3.4. Variant Annotation and Discovery
5.4. Drug discovery services
5.5. Differential gene expression analysis
5.6. Database and management services
5.7. Others
CHAPTER 6. GLOBAL BIOINFORMATICS SERVICES MARKET – BY SPECIALTY
6.1. Introduction
6.2. Medical Biotechnology
6.3. Animal biotechnology
6.4. Plant biotechnology
6.5. Environmental biotechnology
6.6. Forensic biotechnology
CHAPTER 7. GLOBAL BIOINFORMATICS SERVICES MARKET – BY
APPLICATION
7.1. Introduction
7.2. Genomics
7.3. Chemoinformatics & Drug Design
7.4. Proteomics
7.5. Transcriptomics
7.6. Metabolomics
7.7. Other
CHAPTER 8. GLOBAL BIOINFORMATICS SERVICES MARKET - BY END USER
8.1. Introduction
8.2. Academic institutes & research centres
8.3. Hospitals & Clinics
8.4. Pharmaceutical & biotechnology companies
8.5. Others
CHAPTER 9. GLOBAL BIOINFORMATICS SERVICES MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL BIOINFORMATICS SERVICES MARKET - COMPANY
PROFILES
10.1. IBM Life Sciences,
10.2. Illumina Inc.,
10.3. Bruker Daltonics Inc.,
10.4. Accelrys Inc.,
10.5. Strand Life Sciences,
10.6. Life Technologies Corporation,
10.7. Nonlinear Dynamics,
10.8. ID Business Solutions,
10.9. Perkinelmer Inc.,
10.10. 3rd Millennium Inc.,
10.11. Applied Biological Materials.,
10.12. Qiagen N.V.,
10.13. Agilent Technologies
10.14. Source Bioscience
10.15. Thermo Fisher Scientific
CHAPTER 11. GLOBAL BIOINFORMATICS SERVICES MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
